Tilray Brands (NASDAQ:TLRY) Shares Gap Up – Still a Buy?

Tilray Brands, Inc. (NASDAQ:TLRY)’s share price gapped up before the market opened on Friday . The stock had previously closed at $9.13, but opened at $10.05. Tilray Brands shares last traded at $9.1940, with a volume of 6,035,435 shares changing hands.

Key Headlines Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray reported record Q2 net revenue of about $218 million and said international medical cannabis and its pharma business showed strong growth; management also highlighted a favorable U.S. federal cannabis rescheduling catalyst. GlobeNewswire Release
• Positive Sentiment: Tilray moved to a net‑cash position (about $292M in cash & marketable securities and ~ $30M net cash reported) — a material balance‑sheet improvement that reduces financial risk and supports growth/expansion plans. FinanzNachrichten
• Neutral Sentiment: Company reaffirmed full‑year adjusted EBITDA guidance, which stabilizes expectations and is a near‑term catalyst investors can model against. Yahoo — Opportunity Analysis
• Neutral Sentiment: Coverage and notes from market media flagged TLRY as a top mover today, increasing visibility and trading interest (volume can amplify price moves). MSN Movers
• Negative Sentiment: Despite revenue beat vs. estimates (~$217.5M actual vs. ~$211.2M est.), Tilray missed EPS expectations badly (reported -$0.41 vs. consensus -$0.14), and reported a large negative net margin — signaling ongoing profitability challenges. MarketBeat Earnings Summary
• Negative Sentiment: Q2 earnings call/transcripts show management is still navigating margin pressure and integration complexity; investors should monitor commentary for cost‑control progress and guidance detail. Earnings Call Transcript

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on TLRY shares. Atb Cap Markets raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 10th. Wall Street Zen raised Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Saturday, October 11th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Tilray Brands has an average rating of “Hold” and a consensus target price of $20.00.

Tilray Brands Stock Performance

The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.56 and a current ratio of 2.62. The stock has a market capitalization of $1.05 billion, a P/E ratio of -0.41 and a beta of 1.77. The business has a 50-day moving average price of $10.19 and a 200 day moving average price of $10.50.

Tilray Brands (NASDAQ:TLRY) last released its earnings results on Thursday, January 8th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.27). Tilray Brands had a negative return on equity of 6.79% and a negative net margin of 258.54%.The company had revenue of $217.51 million during the quarter, compared to the consensus estimate of $211.15 million. During the same period last year, the firm posted ($0.03) earnings per share. As a group, sell-side analysts forecast that Tilray Brands, Inc. will post -0.2 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Silverlake Wealth Management LLC purchased a new position in Tilray Brands in the 3rd quarter worth approximately $25,000. Oppenheimer & Co. Inc. bought a new position in shares of Tilray Brands during the third quarter valued at $25,000. Unified Investment Management purchased a new stake in shares of Tilray Brands during the third quarter valued at $26,000. J.W. Cole Advisors Inc. increased its holdings in Tilray Brands by 203.2% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock worth $30,000 after buying an additional 48,177 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new position in Tilray Brands in the 3rd quarter worth about $30,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.